AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Press Release: SkyePharma to acquire 100% of RTP Pharma Inc; signs agreement to fund new product development - HFA-Formoterol and RTP's Propofol.

Chemical Business Newsbase

| March 13, 2002 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

SkyePharma PLC announced the acquisition of 59.8% of the outstanding voting shares of RTP Pharma Inc in return for the issue of SkyePharma Ordinary Shares to the value of $20.6 M, thereby securing ownership of the Canadian company. RTP Pharma is globally respected for its nanoparticulate technology used to improve drug solubility. On 1 Aug 2001, SkyePharma announced that it had paid $20 M in SkyePharma Ordinary Shares and acquired $5 M of Preferred …

Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily